Mao Bai-Ping, Li Linxi, Yan Ming, Ge Renshan, Lian Qingquan, Cheng C Yan
The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.
The Mary Wohlford Laboratory for Male Contraceptive Research, Center for Biomedical Research, Population Council, 1230 York Avenue, New York, New York 10065.
Toxicol Sci. 2019 Nov 1;172(1):75-88. doi: 10.1093/toxsci/kfz180.
During spermatogenesis, cell organelles, and germ cells, most notably haploid spermatids, are transported across the seminiferous epithelium so that fully developed spermatids line-up at the edge of the tubule lumen to undergo spermiation at stage VIII of the cycle. Studies have suggested that the microtubule (MT)-based cytoskeleton is necessary to support these cellular events. However, the regulatory molecule(s) and underlying mechanism(s) remain poorly understood. Herein, we sought to better understand this event by using an adjudin-based animal model. Adult rats were treated with adjudin at low-dose (10 mg/kg b.w.) which by itself had no notable effects on spermatogenesis. Rats were also treated with low-dose adjudin combined with overexpression of 2 endogenously produced blood-testis barrier (BTB) modifiers, namely rpS6 (ribosomal protein S6, the downstream signaling protein of mammalian target of rapamycin complex 1 [mTORC1]) and F5-peptide (a biological active peptide released from laminin-γ3 chain at the Sertoli-spermatid interface) versus the 2 BTB modifiers alone. Overexpression of these 2 BTB modifiers in the testis was shown to enhance delivery of adjudin to the testis, effectively inducing disruptive changes in MT cytoskeletons, causing truncation of MT conferred tracks that led to their collapse across the epithelium. The net result was massive germ cell exfoliation in the tubules, disrupting germ cell transport and cell adhesion across the seminiferous epithelium that led to aspermatogenesis. These changes were the result of disruptive spatial expression of several MT-based regulatory proteins. In summary, MT cytoskeleton supported by the network of MT regulatory proteins is crucial to maintain spermatogenesis.
在精子发生过程中,细胞器和生殖细胞,尤其是单倍体精子细胞,会穿过生精上皮进行运输,以便完全发育的精子细胞排列在小管腔边缘,在周期的第八阶段进行精子释放。研究表明,基于微管(MT)的细胞骨架对于支持这些细胞事件是必要的。然而,调节分子和潜在机制仍知之甚少。在此,我们试图通过使用基于阿地金的动物模型来更好地理解这一事件。成年大鼠接受低剂量(10 mg/kg体重)的阿地金治疗,该剂量本身对精子发生没有显著影响。大鼠还接受了低剂量阿地金与两种内源性产生的血睾屏障(BTB)调节剂过表达的联合治疗,即rpS6(核糖体蛋白S6,雷帕霉素复合物1 [mTORC1]的哺乳动物靶点的下游信号蛋白)和F5肽(在支持细胞 - 精子细胞界面从层粘连蛋白 - γ3链释放的一种生物活性肽),并与单独使用这两种BTB调节剂进行对比。睾丸中这两种BTB调节剂的过表达显示可增强阿地金向睾丸的递送,有效诱导MT细胞骨架的破坏变化,导致MT赋予的轨道截断,进而导致其在上皮细胞中塌陷。最终结果是小管中大量生殖细胞脱落,破坏了生殖细胞的运输以及生精上皮细胞间的粘附,导致无精子症。这些变化是几种基于MT的调节蛋白空间表达紊乱的结果。总之,由MT调节蛋白网络支持的MT细胞骨架对于维持精子发生至关重要。